Impaired Oligodendrocyte Development Following Preterm Birth: Promoting GABAergic Action to Improve Outcomes.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic hypotheses without new human empirical data
PubMed 33634057 · doi:10.3389/fped.2021.618052
What was done
This narrative review synthesized literature on oligodendrocyte development, examining how preterm birth disrupts myelination through the loss of placental neurosteroids acting on GABA_A receptors alongside ex utero stressors such as hypoxia and elevated glucocorticoids. It evaluated the hypothesis that restoring GABAergic inhibitory tone could mitigate white matter injury.
What was found
The abstract details a mechanistic model rather than empirical measurements. Preterm birth abruptly reduces placental neurosteroid support for GABA_A-mediated inhibition, while concurrent stressors elevate excitatory glutamate signaling. This excitation-dominant shift impairs oligodendrocyte maturation and axonal myelination, contributing to diffuse white matter deficits. No specific quantitative data or sample metrics are reported in the abstract.
Why it matters
It provides a mechanistic rationale for investigating GABAergic neurosteroid therapies to prevent diffuse white matter injury and subsequent neurodevelopmental or behavioral deficits in preterm infants.
Limits
The paper is a narrative review presenting mechanistic hypotheses without new clinical or experimental data. The abstract contains no quantitative metrics, systematic search criteria, or clinical trial evidence demonstrating efficacy or safety of GABAergic interventions in human neonates.
Cited by
- supports Preterm birth disrupts the GABA-to-glutamate excitatory-inhibitory balance in neural development.